09.08.2017 Views

Psoriasis Treatment Market

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Is Expected To Reach US$<br />

12.8 Bn By 2025 – Credence Research<br />

According to the latest market report published by Credence Research, Inc. “<strong>Psoriasis</strong> <strong>Treatment</strong><br />

<strong>Market</strong> – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global <strong>Psoriasis</strong><br />

<strong>Treatment</strong> market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by<br />

2025, expanding at a CAGR of 5.4% from 2017 to 2025.<br />

Browse the full report <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> – Growth, Future Prospects and<br />

Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/psoriasistreatment-market<br />

<strong>Market</strong> Insights<br />

<strong>Psoriasis</strong> is a chronic, inflammatory, painful skin disease for which there is no cure with great<br />

negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation<br />

and to stop the skin cells from growing quickly. <strong>Psoriasis</strong> treatment market is rapidly growing due<br />

to factors such as growing prevalence in some countries, significant unmet needs, promising<br />

pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of<br />

study, global psoriasis treatment market is segmented on the basis of drug class such as TNF<br />

Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed<br />

that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its<br />

long-term safety with lower risk of infection and malignancy. <strong>Psoriasis</strong> treatment market is<br />

categorized on the basis of route of administration such as topical, oral and parenteral therapeutic<br />

drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more<br />

effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would<br />

show significant growth during forecast period because newly approved biologics are generally<br />

preferred in moderate to severe psoriasis. <strong>Psoriasis</strong> treatment market is currently dominated by<br />

North America, factors such as higher cost of therapy, higher number of psoriasis patient,<br />

government reimbursement policies fueling the growth of psoriasis treatment market in North<br />

America.<br />

Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469


<strong>Market</strong> Competition Assessment:<br />

The psoriasis treatment market is observed to be highly competitive and comprises large number<br />

of players. However, the market is currently dominated by few players such as AbbVie Inc.,<br />

Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company,<br />

Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel<br />

Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.<br />

Key <strong>Market</strong> Movements:<br />

<br />

<br />

<br />

Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher<br />

treatment compliance and favorable reimbursement policies in some countries are driving<br />

the market growth of psoriasis treatment worldwide.<br />

Due to the high unmet needs, vendors in the market are focusing in development of ideal<br />

treatment, promising pipeline molecule, rising access for the treatment medication in some<br />

developing countries, increase in incidence of psoriasis and skin disorders would fuel the<br />

growth of psoriasis treatment market during forecast period.<br />

However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects<br />

associated with the use of medication which would negatively impact the growth of<br />

psoriasis treatment market.<br />

Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469


Table of Content<br />

Chapter 1 Preface<br />

1.1 Report Description<br />

1.1.1 Purpose of the Report<br />

1.1.2 Target Audience<br />

1.1.3 USP and Key Offerings<br />

1.2 Research Scope<br />

1.3 Research Methodology<br />

1.3.1 Phase I – Secondary Research<br />

1.3.2 Phase II – Primary Research<br />

1.3.3 Phase III – Expert Panel Review<br />

1.3.4 Assumptions<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

Chapter 2 Executive Summary<br />

2.1 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Snapshot<br />

2.2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, Drug Class<br />

2.3 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, Type<br />

2.4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Share, by Geography, 2016 (Value %)<br />

Chapter 3 <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Analysis<br />

3.1 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Overview<br />

3.2 <strong>Market</strong> Dynamics<br />

3.2.1 <strong>Market</strong> Drivers<br />

3.2.2 Challenges<br />

3.2.3 Opportunities<br />

3.3 Pipeline Analysis in <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>


3.4 Global Epidemiology Data for <strong>Psoriasis</strong><br />

3.5 Comparative study of <strong>Psoriasis</strong> Therapeutics<br />

3.5.1 Tremfya (Guselkumab)<br />

3.5.2 Siliq (Brodalumab)<br />

3.5.3 Taltz (Ixekizumab)<br />

3.6 Attractive Investment Proposition<br />

3.7 Competitive Landscape of Key Players in <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong><br />

Chapter 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class<br />

4.1 Overview<br />

4.2 Top 3 Countries<br />

4.3 TNF Inhibitors<br />

4.4 Vitamin D Analogues<br />

4.5 Interleukin Blockers<br />

4.6 Topical Corticosteroids<br />

4.7 Other<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

Chapter 5 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type<br />

5.1 Overview<br />

5.2 Top 3 Countries<br />

5.3 Plaque psoriasis<br />

5.4 Guttate psoriasis<br />

5.5 Flexural or inverse psoriasis<br />

5.6 Psoriatic arthritis<br />

5.7 Other


Chapter 6 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, By Geography<br />

6.1 Preface<br />

6.2 North America (U.S. & Canada)<br />

6.2.1 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />

6.2.2 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />

6.2.3 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />

6.3 Europe (U.K., Germany & Rest of Europe)<br />

6.3.1 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />

6.3.2 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />

6.3.3 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />

6.4 Asia Pacific (China, Japan and Rest of APAC)<br />

6.4.1 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />

6.4.2 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />

6.4.1 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />

6.5 Latin America (Brazil, Mexico and Rest of LATAM)<br />

6.5.1 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />

6.5.2 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />

6.5.3 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />

6.6 Middle East and Africa (GCC and Rest of MEA)<br />

6.6.1 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />

6.6.2 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />

6.6.3 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

Chapter 7 Company Profiles<br />

7.1 AbbVie Inc.<br />

7.2 Amgen Inc.


7.3 AstraZeneca<br />

7.4 Biogen<br />

7.5 Boehringer Ingelheim<br />

7.6 Celgene<br />

7.7 Eli Lilly and Company<br />

7.8 Johnson & Johnson<br />

7.9 LEO Pharma A/S<br />

7.10 Merck & Co., Inc.<br />

7.11 Novartis AG<br />

7.12 Pfizer, Inc.<br />

7.13 Stiefel Laboratories Inc. (GlaxoSmithKline plc)<br />

7.14 Sun Pharmaceutical Industries<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

List Of Table<br />

TABLE 1 <strong>Market</strong> Positioning of Key Players in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong><br />

TABLE 2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015 – 2025 (US$ Bn)<br />

TABLE 3 Top 3 Countries in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

TABLE 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015 – 2025 (US$ Bn)<br />

TABLE 5 Top 3 Countries in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

TABLE 6 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Geography, 2015 – 2025 (US$ Bn)<br />

TABLE 7 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />

TABLE 8 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />

TABLE 9 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />

TABLE 10 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />

TABLE 11 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />

TABLE 12 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)


TABLE 13 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />

TABLE 14 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />

TABLE 15 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />

TABLE 16 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />

TABLE 17 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />

TABLE 18 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />

TABLE 19 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />

TABLE 20 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />

TABLE 21 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />

TABLE 22 AbbVie Inc.: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 23 Amgen Inc.: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 24 AstraZeneca: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 25 Biogen: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 26 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 27 Celgene: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

TABLE 28 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 29 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 30 LEO Pharma A/S: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 31 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)


TABLE 32 Novartis AG: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 33 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product<br />

Position/Portfolio; News Coverage)<br />

TABLE 34 Stiefel Laboratories Inc. (GlaxoSmithKline plc): Company Snapshot (Business Description;<br />

Financial Information; Product Position/Portfolio; News Coverage)<br />

TABLE 35 Sun Pharmaceutical Industries: Company Snapshot (Business Description; Financial Information;<br />

Product Position/Portfolio; News Coverage)<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />

List Of Figures<br />

FIG. 1 <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>: Research Methodology<br />

FIG. 2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2016 (US$ Bn)<br />

FIG. 3 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2016 (US$ Bn)<br />

FIG. 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Share, by Geography, 2016 (Value %)<br />

FIG. 5 Attractive Investment Proposition: Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Geography, 2016<br />

FIG. 6 Global TNF Inhibitors <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 7 Global Vitamin D Analogues <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 8 Global Interleukin Blockers <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 9 Global Topical Corticosteroids <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 10 Global Other <strong>Psoriasis</strong> Medication <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 11 Global Plaque <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 12 Global Guttate <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 13 Global Flexural or Inverse <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 14 Global Psoriatic Arthritis <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

FIG. 15 Global Other Types of <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />

Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market


About Credence Research:<br />

Credence Research is a worldwide market research and counseling firm that serves driving organizations,<br />

governments, non legislative associations, and not-for-benefits. We offer our customers some assistance<br />

with making enduring enhancements to their execution and understand their most imperative objectives.<br />

Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.<br />

For More Information, Visit: http://www.credenceresearch.com/<br />

Media Contact<br />

Company Name: Credence Research<br />

Contact Person: Chris Smith,<br />

Designation: Global Sales Manager<br />

Phone: +1-800-361-8290 FREE<br />

Address: 105 N 1st ST #429, SAN JOSE,<br />

CA 95103<br />

E-mail: sales@credenceresearch.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!